{"@context":"https:\/\/schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"A phase III open-label, randomized, controlled study to evaluate the efficacy and safety of petosemtamab compared with investigator’s choice monotherapy treatment in previously treated patients with incurable, metastatic\/recurrent head and neck squamous cell carcinoma.","item":"https:\/\/www.regionalcancercare.org\/trials\/a-phase-iii-open-label-randomized-controlled-study-to-evaluate-the-efficacy-and-safety-of-petosemtamab-compared-with-investigators-choice-monotherapy-treatment-in-previously-treated-patients-with-i\/#breadcrumbitem"}]}